Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05757908 · ClinicalTrials.gov registry record · NA
Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist
A NA study of Moderate Asthma, sponsored by Koneksa Health.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 9
- Study locations
NCT05757908: Completed NA study of Moderate Asthma, sponsored by Koneksa Health.
NCT05757908 is a NA study of Moderate Asthma that has completed, run by Koneksa Health. The registered enrollment target is 29 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05757908, a NA study of Moderate Asthma, has completed, sponsored by Koneksa Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 9
- Study locations
Study Summary
The goal of this interventional study is to compare at-home mobile spirometry to in-clinic spirometry in participants with moderate asthma while taking a long-acting beta agonist (LABA). The main questions it aims to answer are: * Do at-home mobile spirometry and in-clinic spirometry assessments show a similar treatment effect (measured changes in FEV1) with the addition of LABA? * Is at-home mobile spirometry as accurate as in-clinic spirometry in showing treatment effects (changes in FEV1)? Participants will be asked to: * Take standard of care LABA treatment once or twice a day * Complete at-home mobile spirometry testing twice a day * Complete asthma questionnaires twice a day * Complete device use questionnaires * Wear a wrist device (like a watch) to track physical activity and vital signs * Visit the clinic for in-clinic spirometry testing once a week for 8 weeks
Primary Outcome
Detection of treatment effect as measured by change from baseline in morning FEV1 measured in change over time for at-home mobile and in-clinic Spirometry
Conditions Studied
Interventions
- DRUG Long-Acting Beta Agonist
Study Locations (9)
South Carolina
- Clinical Research of Rock Hill - Rock Hill
- Spartanburg Medical Research - Spartanburg
Texas
- El Paso Pulmonary Association - El Paso
- South Texas Allergy & Asthma Medical Professionals Research - San Antonio
Alabama
- AllerVie Research Clinic - Birmingham
Georgia
- AllerVie Research Clinic - Columbus
Massachusetts
- Northeast Medical Research Associates, Inc. - North Dartmouth
Nebraska
- The Asthma & Allergy Center, PC - Bellevue
North Carolina
- American Health Research - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2023-04-21 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
What the finished NCT05757908 record still lists
NCT05757908 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Moderate Asthma appearing as the primary indexed condition, and to 1 intervention - of which Long-Acting Beta Agonist is the first listed.
NCT05757908 lists 9 locations in 7 states (South Carolina, Texas, Alabama).
Frequently Asked Questions
What is clinical trial NCT05757908 about?
NCT05757908 is a clinical study titled "Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist". The goal of this interventional study is to compare at-home mobile spirometry to in-clinic spirometry in participants with moderate asthma while taking a long-acting beta agonist (LABA). The main questions it aims to answer are: * Do at-home mobile spirometry and in-clinic spirometry assessments s...
What is the current status of trial NCT05757908?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2023-04-21. Estimated completion is 2023-11-29.
What conditions does trial NCT05757908 study?
This clinical trial studies the following conditions: Moderate Asthma.
What interventions are being tested in trial NCT05757908?
The interventions under investigation include: Long-Acting Beta Agonist (DRUG).
Who is sponsoring clinical trial NCT05757908?
This trial is sponsored by Koneksa Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05757908 being conducted?
This trial has 9 study locations across Alabama, Georgia, Massachusetts, Nebraska, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05757908's enrollment target sits among peer trials
29 1702nd of 2000 higher than 297 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI